Several pieces of research have indicated that the overexpression of EGFR is related to the low survival rate, frequent lymph node metastasis and poor chemotherapy sensitivity of NSCLC patients [7,8]. This evidence concerns the gene EGFR and non-small cell lung carcinoma.